Literature DB >> 8269305

Idiopathic ventricular tachycardia and fibrillation.

B Belhassen1, S Viskin.   

Abstract

Important data have recently been added to our understanding of sustained ventricular tachyarrhythmias occurring in the absence of demonstrable heart disease. Idiopathic ventricular tachycardia (VT) is usually of monomorphic configuration and can be classified according to its site of origin as either right monomorphic (70% of all idiopathic VTs) or left monomorphic VT. Several physiopathological types of monomorphic VT can be presently individualized, according to their mode of presentation, their relationship to adrenergic stress, or their response to various drugs. The long-term prognosis is usually good. Idiopathic polymorphic VT is a much rarer type of arrhythmia with a less favorable prognosis. Idiopathic ventricular fibrillation may represent an underestimated cause of sudden cardiac death in ostensibly healty patients. A high incidence of inducibility of sustained polymorphic VT with programmed ventricular stimulation has been found by our group, but not by others. Long-term prognosis on Class IA antiarrhythmic medications that are highly effective at electrophysiologic study appears excellent.

Entities:  

Mesh:

Year:  1993        PMID: 8269305     DOI: 10.1111/j.1540-8167.1993.tb01236.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  16 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  The cardiologists' worst nightmare sudden death from "benign" ventricular arrhythmias.

Authors:  Sami Viskin; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

3.  Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.

Authors:  N Sumitomo; K Harada; M Nagashima; T Yasuda; Y Nakamura; Y Aragaki; A Saito; K Kurosaki; K Jouo; M Koujiro; S Konishi; S Matsuoka; T Oono; S Hayakawa; M Miura; H Ushinohama; T Shibata; I Niimura
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 4.  Ventricular arrhythmias and the His-Purkinje system.

Authors:  Michel Haissaguerre; Edward Vigmond; Bruno Stuyvers; Meleze Hocini; Olivier Bernus
Journal:  Nat Rev Cardiol       Date:  2016-01-04       Impact factor: 32.419

Review 5.  Current treatment recommendations in antiarrhythmic therapy.

Authors:  I C Van Gelder; J Brügemann; H J Crijns
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

6.  Genetic analysis of the cardiac sodium channel gene SCN5A in Koreans with Brugada syndrome.

Authors:  Dong-Jik Shin; Yangsoo Jang; Hyun-Young Park; Jong Eun Lee; Keumjin Yang; Eunmin Kim; Yoonjung Bae; Jongmin Kim; Jeongki Kim; Sung Soon Kim; Moon Hyoung Lee; Mohamed Chahine; Sungjoo Kim Yoon
Journal:  J Hum Genet       Date:  2004-08-26       Impact factor: 3.172

7.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

Review 8.  Radiofrequency Ablation to Prevent Sudden Cardiac Death.

Authors:  Moustapha Atoui; Sampath Gunda; Dhanunjaya Lakkireddy; Srijoy Mahapatra
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Apr-Jun

9.  Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2.

Authors:  B B Lerman; B Dong; K M Stein; S M Markowitz; J Linden; D F Catanzaro
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

10.  Ranolazine for the suppression of ventricular arrhythmia: a case series.

Authors:  Eric Yeung; Mori J Krantz; Joseph L Schuller; Rita A Dale; Mark C Haigney
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-02-17       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.